from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
These could be outstanding buy and hold options for ASX investors
-
Ava Risk Group share price rockets 45% on quarterly report
-
AstraZeneca beats forecasts on strong drug sales, backs outlook
-
ASX 200 rises 0.75%, Fortescue impresses and Macquarie remains robust